Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Cardiology/Vascular Diseases
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Abbott Laboratories
Approval Status: Approved February 1998
Treatment Area: high triglyceride levels
Tricor, a micronized form of the drug fenofibrate, has been
approved for the treatment of very high triglyceride levels. Tricor
is indicated as an adjunct to diet for the treatment of adults with
very high serum triglyceride levels, specifically Types IV and V
hyperlipidemia, who are not appropriately controlled by diet alone
and are at risk of pancreatitis.
